Browsing by Author Lanzetta, P

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2013Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature reviewMitchell, Paul (Ronald); Lanzetta, P; Veritti, Daniele; Wolf, Sebastian; Western Clinical School: Westmead Millennium InstituteDifferent antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review, The British Journal of Ophthalmology, vol.97, 12, 2013,pp 1497-1507
2012Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implantMitchell, Paul (Ronald); Haller, Julia A.; Kowalski, Jonathon; Kuppermann, Baruch; Lanzetta, P; Whitcup, Scott M.; Wong, Tien Yin; Yeh, Wei-Shi; Western Clinical School: Westmead Millennium InstituteEffect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant, Ophthalmology, vol.119, 6, 2012,pp 1190-1198
2010The effects of a flexible visual acuity-driven ranibizumab treatment regimen in age-related macular degeneration: outcomes of a drug and disease modelMitchell, Paul (Ronald); Holz, Frank; Korobelnik, J-F; Lanzetta, P; Markabi, Sabri; Schmidli, Heinz; Schmidt-Erfurth, U; Weichselberger, Andreas; Wolf, Sebastian; Western Clinical School: Westmead Millennium InstituteThe effects of a flexible visual acuity-driven ranibizumab treatment regimen in age-related macular degeneration: outcomes of a drug and disease model, Investigative Ophthalmology & Visual Science, vol.51, 1,pp 405-412
2010Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trialsMitchell, Paul (Ronald); Holz, Frank; Korobelnik, J-F; Lanzetta, P; Prunte, C; Schmidt-Erfurth, U; Tano, Yasuo; Wolf, S; Western Clinical School: Westmead Millennium InstituteRanibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials, British Journal of Ophthalmology, vol.94, N/A,pp 2-13
2014Three-Year Outcomes of Individual Ranibizumab Treatment in Patients with Diabetic Macular Edema. The RESTORE Extension StudyMitchell, Paul; Bouazza, Abdelkader Si; Gerstner, Ortrud; Holz, Frank; Lang, Gabriele E.; Lanzetta, P; Massin, Pascale; Osborne, Aaron; Schlingemann, Reinier O.; Schmidt-Erfurth, U; Shen, Haige; Western Clinical School: Westmead Millennium InstituteThree-Year Outcomes of Individual Ranibizumab Treatment in Patients with Diabetic Macular Edema. The RESTORE Extension Study, Ophthalmology, vol.121, 5, 2014,pp 1045-1053
2015Treat-And-Extend Regimens with Anti-Vegf Agents in Retinal DiseasesMitchell, Paul; Devenyi, Robert; Framme, Carsten; Freund, K Bailey; Galic, John; Herbert, Edward; Hoerauf, Hans; Korobelnik, Jean Francois; Lanzetta, P; Michels, Stephan; Mones, Jordi; Regillo, Carl; Tadayoni, Ramin; Talks, James; Wolf, Sebastian; Western Clinical School: Westmead Institute for Medical ResTreat-And-Extend Regimens with Anti-Vegf Agents in Retinal Diseases, Retina: the Journal of Retinal and Vitreous Diseases, vol.35, 8, 2015,pp 1489-1506